CARDIOASSIST LIMITED

Active Winchester

Other research and experimental development on natural sciences and engineering

0 employees website.com
Other research and experimental development on natural sciences and engineering
C

CARDIOASSIST LIMITED

Other research and experimental development on natural sciences and engineering

Founded 1 Oct 2004 Active Winchester, England 0 employees website.com
Other research and experimental development on natural sciences and engineering
Accounts Submitted 8 May 2025 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 5 Nov 2025 Next due 15 Oct 2026 4 months remaining
Net assets £-2K £40K 2024 year on year
Total assets £4 £11K 2024 year on year
Total Liabilities £2K £51K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

17 North Drive Littleton Winchester SO22 6QA England

Full company profile for CARDIOASSIST LIMITED (05247579), an active company based in Winchester, England. Incorporated 1 Oct 2004. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

-£1.89k

Increased by £40.20k (+96%)

Total Liabilities

£1.89k

Decreased by £50.94k (-96%)

Turnover

N/A

Employees

N/A

Debt Ratio

47250%

Increased by 46758 (+9504%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Heart Biotech Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Heart Biotech Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

CARDIOASSIST LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Nov 2025GazetteGazette Notice Voluntary
6 Nov 2025DissolutionDissolution Application Strike Off Company
5 Nov 2025Confirmation StatementConfirmation statement made on 1 Oct 2025 with no updates
8 May 2025AccountsAnnual accounts made up to 30 Sept 2024
14 Oct 2024Confirmation StatementConfirmation statement made on 1 Oct 2024 with no updates
18 Nov 2025 Gazette

Gazette Notice Voluntary

6 Nov 2025 Dissolution

Dissolution Application Strike Off Company

5 Nov 2025 Confirmation Statement

Confirmation statement made on 1 Oct 2025 with no updates

8 May 2025 Accounts

Annual accounts made up to 30 Sept 2024

14 Oct 2024 Confirmation Statement

Confirmation statement made on 1 Oct 2024 with no updates

Recent Activity

Latest Activity

Gazette Notice Voluntary

6 months ago on 18 Nov 2025

Dissolution Application Strike Off Company

6 months ago on 6 Nov 2025

Confirmation statement made on 1 Oct 2025 with no updates

6 months ago on 5 Nov 2025

Annual accounts made up to 30 Sept 2024

1 years ago on 8 May 2025

Confirmation statement made on 1 Oct 2024 with no updates

1 years ago on 14 Oct 2024